I caught up with Brad Smith, managing director and partner at Vertess, recently and he said the mergers and acquisition market for HME has been “a wild rollercoaster ride” amid the coronavirus pandemic.
The print issues of HME News are on their way to your mailboxes (if not already there), but I wanted to call your attention to page 22. Here you will find, as you do every month, The Braff Group M&A Insider.
SAN JOSE, Calif. – A&D Company has entered into a definitive agreement to buy the necessary business assets of Toronto-based Auto Control Medical. The deal allows A&D to expand its product range and application experience across the Americas.
LOUISVILLE, Ky. – Amerita, a subsidiary of PharMerica, a national provider of institutional and specialty pharmacy services, has acquired Alternacare Infusion Pharmacy, an Olathe, Kan.-based specialty home infusion provider.
A. The primary theoretical components are definitely in play—income, growth, and risk. The lower the go-forward risk and the greater the go-forward growth opportunity, the greater the multiple of income a buyer is likely to offer a provider.
